Radiopaque Bone Cement for Fracture Fixation

A new radiopaque bone cement called Symphony VR has been developed for use in the fixation of pathologic fractures of the vertebral body using vertebroplasty or kyphoplasty procedures. The bone cement has been cleared by the U.S. Food and Drug Administration (FDA).

Painful vertebral compression fractures can result from osteoporosis, benign lesions (hemangioma), and metastatic cancers such as myeloma. The cement comes premixed with a radiopacifier, giving a spine doctor longer working time and a lower exothermic temperature while using less monomer than other products. A bone-void filling system called Plexis utilizes a patented mixing and delivery technology that gives the surgeon maximum control. Symphony VR is the product of Advanced Biomaterial Systems, Inc. (ABS, Chatam, NJ, USA; www.advbiomat.com).

"This FDA clearance now allows ABS to market its Plexis mixing and delivery system together with ABS's Symphony VR radiopaque bone cement as a complete and controlled solution to spine physicians for stabilizing spinal compression fractures for use in either vertebroplasty or kyphoplasty procedures,” noted Pete Carr, president and CEO of ABS.






Related Links:
Advanced Biomaterial Systems